{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:20:55Z","timestamp":1787721655360,"version":"build-2784847793"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Inflammation plays a critical role in acute ischemic stroke (AIS) pathophysiology and may influence outcomes after endovascular treatment (EVT). However, the incremental prognostic value of inflammatory cytokines beyond conventional predictors remains unclear. This study aimed to investigate the association of cytokines with 90-day functional outcomes in EVT-treated AIS patients and evaluate their value in prognostic modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the prospective DETECT2-China registry, we included consecutive large vessel occlusion patients undergoing EVT between March 2022 and March 2025. Plasma cytokines were measured within 24\u202fh post-EVT. The primary outcome was 90-day poor functional outcome (modified Rankin Scale [mRS] 3\u20136). Multivariable logistic regression identified independent predictors. Clinical, cytokine, and combined models were constructed and evaluated using receiver operating characteristic (ROC) curves, calibration, decision curve analysis (DCA), and reclassification metrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 139 included patients, 77 (55.4%) had 90-day poor outcomes. Serum IL-6 and IL-10 levels were significantly higher in these patients. In multivariable analysis, log\u2082-IL-6 was an independent predictor (OR\u202f=\u202f1.43 per doubling, 95% CI: 1.14\u20131.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002), and log\n                      <jats:sub>2<\/jats:sub>\n                      -IL-10 was significant in Adjusted Model 2 (OR\u202f=\u202f1.86 per doubling, 95% CI: 1.02\u20133.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.041). The combined model achieved superior discrimination (AUC: 0.841, 95% CI: 0.770\u20130.905) compared with the clinical model (AUC: 0.791, 95% CI: 0.717\u20130.865;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.015), with good calibration and clinical net benefit. Reclassification was also improved (continuous NRI: 43.32%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009; IDI: 7.27%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum IL-6 is independently associated with 90-day poor outcome While incorporating cytokines into clinical models may improve prognostic estimation, these exploratory findings require validation in independent cohorts before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1903651","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:47:51Z","timestamp":1787719671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum inflammatory cytokines predict 90-day outcome after endovascular treatment in acute ischemic stroke"],"prefix":"10.3389","volume":"17","author":[{"given":"Guo-Qing","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The 965th Hospital of Chinese PLA","place":["Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Sheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/s0140-6736(24)00642-1","article-title":"Stroke (seminar)","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","article-title":"Inflammation and stroke: an overview","volume":"13","author":"Anrather","year":"2016","journal-title":"Neurotherapeutics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jneuroim.2014.07.015","article-title":"Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis","volume":"274","author":"Bustamante","year":"2014","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"122997","DOI":"10.1016\/j.jns.2024.122997","article-title":"Stroke risk prediction models: a systematic review and meta-analysis","volume":"460","author":"Asowata","year":"2024","journal-title":"J Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.str.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1161\/strokeaha.113.001972","article-title":"Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement","volume":"44","author":"Zaidat","year":"2013","journal-title":"Stroke"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cytogfr.2024.06.002","article-title":"The impact of cytokines in neuroinflammation-mediated stroke","volume":"78","author":"Kumari","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12975-018-0617-z","article-title":"Release of IL-6 after stroke contributes to impaired cerebral autoregulation and hippocampal neuronal necrosis through NMDA receptor activation and upregulation of ET-1 and JNK","volume":"10","author":"Armstead","year":"2019","journal-title":"Transl Stroke Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040470","article-title":"The role of IL-6 in ischemic stroke","volume":"15","author":"Pawluk","year":"2025","journal-title":"Biomolecules"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102982","DOI":"10.1016\/j.redox.2023.102982","article-title":"IL-10 protects against OPC ferroptosis by regulating lipid reactive oxygen species levels post stroke","volume":"69","author":"Wu","year":"2024","journal-title":"Redox Biol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41593-025-01877-7","article-title":"Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent T(reg)-microglia crosstalk","volume":"28","author":"Izzy","year":"2025","journal-title":"Nat Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1000145","DOI":"10.1371\/journal.pmed.1000145","article-title":"Inflammatory markers and poor functional outcome after stroke: a prospective cohort study and systematic review of interleukin-6","volume":"6","author":"Whiteley","year":"2009","journal-title":"PLoS Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/s0140-6736(23)02032-9","article-title":"Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial","volume":"402","author":"Bendszus","year":"2023","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1161\/01.str.31.10.2325","article-title":"Proinflammatory cytokines and early neurological worsening in ischemic stroke","volume":"31","author":"Vila","year":"2000","journal-title":"Stroke"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.2147\/jir.S317147","article-title":"Inflammatory factors as potential markers of early neurological deterioration in acute ischemic stroke patients receiving endovascular therapy\u2014the AISRNA study","volume":"14","author":"Deng","year":"2021","journal-title":"J Inflamm Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2147\/jir.S419087","article-title":"Association between inflammatory burden index and unfavorable prognosis after endovascular thrombectomy in acute ischemic stroke","volume":"16","author":"Du","year":"2023","journal-title":"J Inflamm Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/b978-0-12-394309-5.00006-7","article-title":"Cell biology of ischemia\/reperfusion injury","volume":"298","author":"Kalogeris","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.289.5.579","article-title":"Alcohol consumption and risk of stroke: a meta-analysis","volume":"289","author":"Reynolds","year":"2003","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.annepidem.2007.01.005","article-title":"Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses","volume":"17","author":"Fillmore","year":"2007","journal-title":"Ann Epidemiol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1903651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:47:58Z","timestamp":1787719678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1903651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":24,"alternative-id":["10.3389\/fneur.2026.1903651"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1903651","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1903651"}}